-

Trinity Life Sciences Recognized in Gartner® Hype Cycle™ for Life Sciences Commercial Operations, 2023

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a leader in global life sciences commercialization solutions, was identified as a Sample Vendor in four sections within the July 2023 Gartner Hype Cycle for Life Sciences Commercial Operations report. The sections where Trinity was named are:

- AI (Artificial Intelligence) in Commercial Operations
- Advanced Decision Support for Sales
- Personalization Engines in LS (Life Science)
- D&A (Data & Analytics) Platforms in Commercial LS

As Gartner explains: “Life science organizations strive to balance innovation and operational value delivery. This Hype Cycle provides CIOs with strategic input by tracking maturity levels and adoption rates of key technologies to guide commercialization planning and investments.”[1]

In response, Tim Wohlgemut, SVP of New Products & Strategies at Trinity Life Sciences commented: “Trinity is laser-focused on providing solutions that enable life sciences companies to realize the value of data across commercial activities with expertise and technology. Our work with clients includes capabilities relevant across commercial operations, including forecasting, omnichannel, data management, real-world evidence and AI. We welcome being mentioned by Gartner.”

Life sciences executives can download the report here.

Gartner Disclaimer

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally, Hype Cycle is a registered trademark of Gartner, Inc. and/or its affiliates and is used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

[1] Gartner, Hype Cycle for Life Sciences Commercial Operations, Animesh Gandhi, published 20 July 2023.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With over 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

Media Contact:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

Media Contact:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...

GSK, Amgen and AstraZeneca Lead the Pack in Trinity’s 2025 Digital Marketing Competency Report

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization, today announced the release of its 5th Annual TGaS Digital Marketing Competency Report, a three-part series benchmarking the digital marketing presence of more than 150 biopharma brands. The 2025 edition reveals a significant leap forward in the industry’s digital sophistication, with a 19% increase in Proficient brands and a surge of innovation in patient engagement strategies. The report ranks each b...

Trinity Expands Global Footprint with Acquisition of EVERSANA’s APACME Advisory Services

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a leader in global life sciences commercialization solutions and recognized for being a strategic, tech-enabled commercialization company that empowers pharma, biotech, and medtech organizations to advance medical innovations, announced today the acquisition of EVERSANA’s advisory services operation in Asia-Pacific and the Middle East (APACME). The strategic acquisition will transition EVERSANA’s advisory services operation in APACME to Trinity, further...
Back to Newsroom